Change from baseline fasting plasma glucose was -@ mmol/l in the albiglutide group and +@ mmol/l in the placebo group ( p < @ ) ; a significantly higher percentage of patients reached the HbA@c goals with albiglutide ( p < @ ) , and the rate of hyperglycaemia rescue up to week @ for albiglutide was @ versus @ % for placebo ( p < @ ) .